← Evidence map

ArticleBlood advances2022

Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation.

Siok-Keen Tey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34607349